Tuesday, November 14, 2006

Patents versus Patients

Oxfam has issued a report today suggesting that rich countries continue to undermine the Doha Declaration (a ministerial agreement of the World Trade Organisation). The agreement was supposed to ensure that poor people living in the developing world will be able to access essential drugs in an affordable and sustainable manner. Oxfam concludes: 'Trade rules remain a major barrier to accessing affordable versions of patented medicines (generic medicines). The prevalence of debilitating and life-threatening diseases in poor countries is growing, but medicines are simply not available.'

No comments:

Post a comment

Note: only a member of this blog may post a comment.

COVID19 and the ethics of hospital triage decision-making

There is a lot of talk these days about the predicted coming wave of COVID19 patients needing ICU beds and ventilators in particular, and th...